NCT05683418 2026-04-22A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast CancerTotus MedicinesPhase 1 Recruiting241 enrolled
NCT02684032 2022-07-27A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast CancerCelcuity IncPhase 1 Completed141 enrolled